No abstract available
Keywords:
MRGPRX2; allergy testing; anaphylaxis; neuromuscular blocking agent; non-IgE-mediated allergic reaction; rocuronium.
MeSH terms
-
Adrenergic alpha-Agonists / therapeutic use
-
Adult
-
Anaphylaxis / chemically induced*
-
Anaphylaxis / drug therapy
-
Anaphylaxis / genetics
-
Glucocorticoids / therapeutic use
-
Humans
-
Intraoperative Complications / chemically induced*
-
Intraoperative Complications / drug therapy
-
Male
-
Methylprednisolone / therapeutic use
-
Mutation / genetics*
-
Nerve Tissue Proteins / genetics*
-
Neuromuscular Nondepolarizing Agents / adverse effects
-
Norepinephrine / therapeutic use
-
Receptors, G-Protein-Coupled / genetics*
-
Receptors, Neuropeptide / genetics*
-
Rocuronium / adverse effects*
Substances
-
Adrenergic alpha-Agonists
-
Glucocorticoids
-
MRGPRX2 protein, human
-
Nerve Tissue Proteins
-
Neuromuscular Nondepolarizing Agents
-
Receptors, G-Protein-Coupled
-
Receptors, Neuropeptide
-
Rocuronium
-
Norepinephrine
-
Methylprednisolone